Add like
Add dislike
Add to saved papers

Sclerotherapy for vascular malformations: complications and a review of techniques to avoid them.

PURPOSE: Interventional radiology has a principal role frequently replacing surgery in the multidisciplinary management of vascular malformations. Having noticed an initial high rate of complications, we examined our early experience to study in detail the outcomes and risks. We also present a review of techniques to reduce these complications.

MATERIALS AND METHODS: Data were collected during a 5-year period on patients who had completed treatment. The two sclerosants used were either 100% alcohol or 3% sodium tetradecyl sulphate (STS) as sole agents, or in combination. We graded early clinical and radiological outcomes. Binary logistic regression analysis was carried out for variables (age, type of vascular malformation and number of sclerotherapy sessions) that may predict the occurrence of complications.

RESULTS: Twenty-four patients (11 males and 13 females) completed treatment during this period and were the subject of this review. There were a total of 46 sessions with an average of two (range: one to five). The mean and median ages were 36.2 and 38 years, respectively. Nineteen patients had venous malformations and five had lymphatic malformations. Most of the vascular malformations were in the head and neck region (66.7%). Although the overall early results were favourable (21 out of 24 patients had partial or complete resolution clinically and radiologically), there were four nerve-related and three skin-related complications. Using alcohol alone (13 patients, 24 sessions) there were one skin and three nerve injuries; with STS alone (five patients, 19 sessions) there was one skin complication; and when in combination (six patients, three sessions) one nerve and one skin complications.

CONCLUSION: More complications were seen with the use of alcohol, including all the nerve-related injuries, prompting a change of practice to favour STS as the primary agent, especially for head and neck lesions.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app